Evidence map›Paper›PMID 25001955›Full record

ArticlePsychoneuroendocrinology2014

Functional effects of polymorphisms on glucocorticoid receptor modulation of human anxiogenic substance-P gene promoter activity in primary amygdala neurones.

Colin W Hay, Lynne Shanley, Scott Davidson, Philip Cowie, Marissa Lear, Peter McGuffin, Gernot Riedel, Iain J McEwan, Alasdair MacKenzie

Open access · hybridAbstract read
In one paragraph

Article in Psychoneuroendocrinology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.3field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. The Role ofBiomolecules · 2025
    Review
  3. Article
  4. Neurobiology of stress · 2023
    Review
  5. Review
  6. Article
  7. Structural insights into glucocorticoid receptor function.Biochemical Society transactions · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Colin W HaySchool of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB39 3UW, Scotland, UK.
Lynne ShanleySchool of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB39 3UW, Scotland, UK.
Scott DavidsonSchool of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB39 3UW, Scotland, UK.
Philip CowieSchool of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB39 3UW, Scotland, UK.
Marissa LearSchool of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB39 3UW, Scotland, UK.
Peter McGuffinMRC SGDP Centre, Institute of Psychiatry, King's College London, DeCrespigny Park, London SE5 8AF3, UK.
Gernot RiedelSchool of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB39 3UW, Scotland, UK.
Iain J McEwanSchool of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB39 3UW, Scotland, UK.
Alasdair MacKenzieSchool of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB39 3UW, Scotland, UK. Electronic address: alasdair.mackenzie@abdn.ac.uk.
University of Aberdeen · GBKing's College London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/D004659/1Biotechnology and Biological Sciences Research Council BB/D524932/1Chief Scientist Office CZB/4/477Medical Research Council G0701003Wellcome TrustWellcome Trust 080980/Z/06/Z
6 · The paper itself

Abstract

Expression or introduction of the neuropeptide substance-P (SP; encoded by the TAC1 gene in humans and Tac1 in rodents) in the amygdala induces anxiety related behaviour in rodents. In addition, pharmacological antagonism of the main receptor of SP in humans; NK1, is anxiolytic. In the current study, we show that the Tac1 locus is up-regulated in primary rat amygdala neurones in response to activation of the glucocorticoid receptor (GR); a classic component of the stress response. Using a combination of bioinformatics, electrophoretic mobility shift assays (EMSA) and reporter plasmid magnetofection into rat primary amygdala neurones we identified a highly conserved GR response sequence (2GR) in the human TAC1 promoter that binds GR in response to dexamethasone (Dex) or forskolin. We also identified a second GR binding site in the human promoter that was polymorphic and whose T-allele is only found in Japanese and Chinese populations. We present evidence that the T-allele of SNPGR increases the activity of the TAC1 promoter through de-sequestration or de-repression of 2GR. The identification of Dex/forskolin response elements in the TAC1 promoter in amygdala neurones suggests a possible link in the chain of molecular events connecting GR activation and anxiety. In addition, the discovery of a SNP which can alter this response may have implications for our understanding of the role of regulatory variation in susceptibility to stress in specific populations.

Indexed as

Polymorphism, Single NucleotidePromoter Regions, GeneticAmygdalaAnimalsAnimals, NewbornAnxietyBase SequenceCells, CulturedColforsinDexamethasoneGene Expression RegulationHumansMolecular Sequence DataNeuronsPrimary Cell CultureRatsColforsinDexamethasoneReceptors, GlucocorticoidSubstance PGene regulationGlucocorticoid receptorSingle nucleotide polymorphismStress and anxietyTAC1 promoter

Identifiers

PMID25001955
PMCPMC4103484
OpenAlexW2119716720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.